DYAI
DYADIC INTERNATIONAL INC
NASDAQ · Healthcare · Biotechnology · US
$0.37
+1.39%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- 12.17x
- P/E 2028E
- —
- P/S forward
- 1.64x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- -6.13x
- Price / sales
- 4.21x
- Price / cash flow
- -1.98x
Enterprise value
- Enterprise value
- $16.6M
- EV / sales
- 4.77x
- EV / EBITDA
- -2.30x
- EV / EBIT
- -2.23x
- Market cap
- $14.6M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026